Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease-Reference-Cited by-同舟云学术

Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease

Published:2021-04-01 Issue:4 Volume:78 Page:407
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Simmering Jacob E.¹,Welsh Michael J.¹²³⁴⁵,Liu Lei⁶,Narayanan Nandakumar S.²,Pottegård Anton⁷

Affiliation:

1. Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City

2. Department of Neurology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City

3. Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City

4. Pappajohn Biomedical Institute, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City

5. Howard Hughes Medical Institute, University of Iowa, Iowa City

6. Center of Stroke, Beijing Institute for Brain Disorders, Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China

7. Department of Public Health, University of Southern Denmark, Odense, Denmark

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2775976/jamaneurology_simmering_2021_oi_200098_1617209051.41766.pdf

Reference37 articles.

1. The epidemiology of Parkinson’s disease: risk factors and prevention.;Ascherio;Lancet Neurol,2016

2. Epidemiology of Parkinson’s disease.;de Lau;Lancet Neurol,2006

3. The incidence of Parkinson’s disease: a systematic review and meta-analysis.;Hirsch;Neuroepidemiology,2016

4. Deep brain stimulation of the subthalamic nucleus reversibly deteriorates stuttering in advanced Parkinson’s disease.;Burghaus;J Neural Transm (Vienna),2006

5. Disease progression continues in patients with advanced Parkinson’s disease and effective subthalamic nucleus stimulation.;Hilker;J Neurol Neurosurg Psychiatry,2005

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exposure to Glycolysis-Enhancing Drugs and Risk of Parkinson’s Disease: A Meta-Analysis;Journal of Parkinson's Disease;2024-09-03

2. Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits;Science Advances;2024-08-23

3. Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson’s disease, Alzheimer’s disease and mortality: An observational cohort study of elderly Medicare enrollees;PLOS ONE;2024-08-22

4. Update: Protective and risk factors for Parkinson disease;Parkinsonism & Related Disorders;2024-08

5. Reprint of: The impact of alpha-1-adrenergic receptor antagonists on the progression of Parkinson disease;Journal of the American Pharmacists Association;2024-08